GL1X · GenesisL1 explorer

MolNFT v1 · #95511 · protein

Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2- (6-fluoro-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-(1,3-thiazol-2- YL)PROPANAMIDE

4ISF: “Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2…”. X-ray diffraction, 3 ligands (1FX, GLC, IOD), 4 pockets (best druggability 0.66). MolNFT v1 #95511 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
4ISF
Type
protein
Length
428 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glucokinase
EC
2.7.1.2
UniProt
P35557
Ligands
1FX, GLC, IOD
Pockets
4 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlucokinase (EC 2.7.1.2)protein42847% helix, 18% strandP35557

Ligands and binding sites

  • 1FX · (2S)-3-cyclohexyl-2-(6-fluoro-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-(1,3-thiazol-2-yl)propanamide · ligand · chains A
  • GLC · alpha-D-glucopyranose · sugar · chains A
  • IOD · Iodide ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12340.660.83251FX
23080.610.7832empty
3690.330.7617empty
4680.300.7412empty

Compared structures

  • 4ISF · Human glucokinase in complex with novel activator… · the same entry in another collection · chain A against A, TM-score 1.00
  • P35557 · AlphaFold monomer V2.0 prediction for hexokinase-4 (P35557) · a predicted model of the same protein · chain A against A, TM-score 0.83

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.